Schedule 13D ownership disclosure
DICE THERAPEUTICS INC
Security class unavailable · CUSIP: 23345J104
Event date: 2023-03-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,660,615
- Percent of class
- 16.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-038414
- Form type
- SC 13D
- Filer
- DICE Therapeutics, Inc.
- CIK
- CIK 1645569
- Filed
- Mar 29, 2023
- Reporting period
- Mar 27, 2023
- Description
- Schedule 13D beneficial ownership